Company Overview of Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. operates as a biopharmaceutical company that develops microRNA-based oncology therapeutics. It offers MRX34 to deliver a mimic of the naturally occurring microRNA tumor suppressor, miR-34, which is lost or under expressed in tumors of patients with various cancers, including cervical cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma (liver cancer), colon cancer, non-small cell lung cancer, and in cancer stem cells. The company was founded in 2007 and is based in Austin, Texas. Mirna Therapeutics, Inc. operates as a subsidiary of Asuragen, Inc.
2150 Woodward Street
Austin, TX 78744
Founded in 2007
Key Executives for Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|InterLink Biotechnologies, LLC||United States|
|ISTO Technologies, Inc.||United States|
|Biocell Laboratories, Inc.||United States|
|Novactyl, Inc.||United States|
|Albemarle Poultry Sciences LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Mirna Therapeutics, Inc., please visit www.mirnatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.